Skip to main content

Table 1 Patient characteristics

From: Distinct temporal characteristics of circulating alveolar epithelial and endothelial injury markers in ARDS with COVID-19

 

Non-ARDS (n = 10)

ARDS (n = 11)

P value

Age, median (IQR), years

57 (30–72)

69 (64–76)

0.2428

Male/female, number

8/2

10/1

0.5865

APACHE2 score, median (IQR)

7 (4.75–9.75)

10 (9.00–14.00)

*0.0204

P/F ratio at admission, median (IQR)

395 (304–454)

155 (108–203)

*< 0.0001

Mechanical ventilation use, number

0

11

*< 0.0001

Laboratory data on admission, median (IQR)

 WBC count, cells/μL

4600 (2525–7925)

7000 (5800–9600)

0.1567

 Neutrophil count, cells/μL

2258 (1268–5416)

5628 (4292–7350)

*0.0430

 Lymphocyte count, cells/μL

1003 (674–1475)

643 (342–788)

*0.0048

 Platelet count, ×103 cells/μL

186 (86–317)

220 (176–287)

0.4262

 D-dimer, μg/mL

0.67 (0.00–1.04)

1.35 (0.65–2.52)

*0.0404

 CRP, mg/dL

0.98 (0.28–2.06)

14.62 (9.09–16.89)

*< 0.0001

 Creatinine, mg/dL

0.75 (0.63–0.87)

0.75 (0.59–0.89)

> 0.9999

 Total bilirubin, mg/dL

0.55 (0.40–0.78)

0.60 (0.50–1.00)

0.5661

Alveolar tissue injury marker levels on admission, median (IQR)

 sRAGE, pg/mL

896 (402–1718)

2328 (1404–4982)

*0.0079

 ANG-2, pg/mL

334 (65–781)

699 (405–2201)

0.1321

 SP-D, pg/mL

2407 (772–3833)

16,596 (6733–21,397)

*0.0062

  1. ARDS acute respiratory distress syndrome, ANG-2 angiopoietin-2, SP-D surfactant protein D, sRAGE soluble form of receptor for advanced glycation end-products, WBC while blood cell, CRP c-reactive protein, IQR interquartile range